|
Thursday 11 February 2010 |
 |
|
08.00 |
Registration & Coffee |
|
|
08.45 |
Welcome |
|
|
|
Panel Discussion: Finance & M&A
| Chair: |
Ms. Stephanie Léouzon, Senior Advisor, Credit Suisse |
| Panellists: |
Matthew Walls, CEO, Epistem Ltd
Thomas Klaue, CFO, Medigene
Alexandra Goll, General Partner, TVM Capital
Simon Turton, Managing Director Healthcare, Warburg Pincus LLC
Peter Llewellyn-Davies, CFO, Wilex AG |
|
|
|
|
Panel Discussion: '2010:Back from the Brink'
| Chair: |
Dr Genghis Lloyd-Harris, Partner, Abingworth Management |
| Panellists: |
Roel Bulthuis, Head of Merck Serono Ventures, Merck Serono Ventures
David Chiswell, CEO, Nabriva
Ulrik Spork, Managing Partner, Novo A/S
Carole Nuechterlein, Head of Venture Funds, Roche Venture Fund
Antoine Papiernik, Managing Partner, Sofinnova Partners |
|
|
|
11.00 |
Break |
|
|
|
Vaccines & Medtech Investment Panels
Exchange Room |
 |
Company Presentations
Auditorium Room |
| Chair: |
Anthony Hartley, Executive Director, Morgan Stanley |
| Panellists: |
Anders Hedegaard, President and CEO, Bavarian Nordic A/S
Wolfgang Renner, CEO, Cytos Biotechnology
Carlton Brown, Founder & CEO, Immune Targeting Systems
Riccardo Manetti, Head, S&E Research & Technology Licensing, Novartis Vaccines & Diagnostics |
|
|
|
|
|
|
|
Medtech Investment Panels
|
|
Company Presentations
|
| Chair: |
Marcus Hosang, General Partner, BioMedPartners |
| Panellists: |
Marion Jung, Principal, Earlybird Venture Capital
Olivier Litzka, Partner, Edmond de Rothschild Investment Partners
Eric Le Royer, CEO, Endosense
Arthur Franken, Partner, Gilde Healthcare Partners
Stan Yakatan, Chairman, Katan Associates |
|
|
|
|
|
|
12.45 |
Networking Lunch – Auditorium |
|
|
| |
|
| 13.45 |
|
| 14.00 |
|
| 14.15 |
|
| 14.30 |
|
| 14.45 |
|
| 15.00 |
|
| 15.15 |
|
| 15.30 |
|
| 16.00 |
|
| 16.15 |
|
| 16.30 |
|
| 16.45 |
|
| 17.00 |
|
Company Presentations
| Exchange Room |
Auditorium Room |
Decision Room |
|
| Biotie Therapies Corp |
Addex Pharmaceuticals Ltd |
Epistem Ltd |
|
| Cosmo Pharmaceuticals |
PolyMedix, Inc. |
TiGenix NV |
|
| CerMed Corp |
tbc |
BRUCELLS s.a |
|
| tbc |
Nabriva Therapeutics AG |
Immune Targeting Systems |
|
| tbc |
Nitec Pharma AG |
Axentis Pharma AG |
|
| Wilex AG |
NOXXON Pharma |
ALRISE Biosystems GmbH |
|
| tbc |
Capstone Therapeutics |
London Genetics Limited |
|
| break |
break |
break |
|
| immatics biotechnologies |
Glycotope |
BioCeramic Therapeutics |
|
| Bavarian Nordic A/S |
ALFAMA, Inc. |
Medical Device Works |
|
| Scancell Limited |
Kenta Biotech AG |
Celonic AG |
|
| Diamyd Medical AB |
ProtAffin Biotechnologie AG |
Sensile Medical AG |
|
| Neovacs |
Affectis Pharmaceuticals AG |
tbc |
|
|
|
|
Question Time
| Moderator: |
Dimitri Dimitriou, CEO, DyoDelta Biosciences |
| Panellists: |
Simon Buckingham, President, Global Corporate and Business Development, Actelion Pharmaceuticals
Naveed Siddiqi, Partner, Nomura Phase4 Ventures |
|
|
|
18.15 |
DyoDelta European Life Science Innovation Awards Ceremony
presented by
Dimitri Dimitriou, CEO, DyoDelta Biosciences |
|
|
18.30 |
Networking Reception Sponsored by DyoDelta Biosciences |
|
|
| |
|
Agenda |
Friday 12 February 2010 |
|
|
08.15 |
Registration & Coffee |
|
|
|
Keynote Speech – Has VC funding changed the structure of deals with pharmaceutical companies?
Fintan Walton, CEO, PharmaVentures |
|
|
|
Trends in Global Regulatory Harmonization: How to Leverage for Competitive Advantages
Peter Honig, Managing Director, PH Regulatory Medical Advisors |
|
|
|
Partnering Panel
| Chair: |
Dimitri Dimitriou,Chief Executive Officer, DyoDelta Biosciences |
| Panellists: |
Shelagh Wilson, VP, Head of European CEEDD, GSK
Margaret Beer, Senior Director and Head, Licensing and External Research, Europe, Merck & Co.
Esteban Pombo Villar, Head of Strategic Alliance Management EU, Novartis Pharma AG
Markus Werner, Director International Licensing, Business Development, Nycomed |
|
|
|
10.45 |
Coffee Break |
|
|
| |
|
| 11.00 |
|
| 11.15 |
|
| 11.30 |
|
| 11.45 |
|
| 12.00 |
|
| 12.15 |
|
| 12.30 |
|
| 12.45 |
|
Pharma Partnering Workshops
Exchange Room |
Company Presentations
Auditorium Room |
|
| Merck & Co. |
Prosensa Therapeutics BV |
|
| Merck Serono |
Accera, Inc |
|
| Novartis Pharma AG |
Galantos Pharma GmbH |
|
| Nycomed International Management GmbH |
NOLabs AB |
|
| Teva Pharmaceutical Industries, Ltd. |
PharmaNeuroBoost NV |
|
| Emotional Brain B.V. |
to-BBB technologies BV |
|
| Lumavita AG |
Savira Pharmaceuticals |
|
| TBC |
TBC |
|
|
|
13.00 - 14.00 |
Networking Lunch & Close of Conference |
|
|
| |
Back to top |
|